Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-01-22 @ 5:19 AM
Study NCT ID:
NCT04402060
Status:
COMPLETED
Last Update Posted:
2022-03-23
First Post:
2020-05-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
Sponsor:
Apellis Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | COVID | View |
| None | Covid-19 | View |
| None | Coronavirus | View |
| None | Coronavirus Infection | View |
| None | Severe Acute Respiratory Syndrome | View |
| None | Severe Acute Respiratory Syndrome Coronavirus 2 | View |
| None | Sars-CoV2 | View |
| None | Ards | View |
| None | Acute Respiratory Distress Syndrome | View |
Keywords: